A drug eluting balloon is a semi-compliant angioplasty balloon that is surrounded by an anti-proliferative medicine. The medicine is ejected to the vessel wall during the inflation of the balloon. The active substance of the balloon is highly lipophilic (dissolved in lipids or fats). The drug eluting balloon homogeneously delivers the drug to the vessel and provides treatment for peripheral artery disease.
This report contains market size and forecasts of Drug Eluting Balloon for Peripheral Artery Disease in global, including the following market information:
Global Drug Eluting Balloon for Peripheral Artery Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Drug Eluting Balloon for Peripheral Artery Disease Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Drug Eluting Balloon for Peripheral Artery Disease companies in 2021 (%)
The global Drug Eluting Balloon for Peripheral Artery Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
3μg/ mm2 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drug Eluting Balloon for Peripheral Artery Disease include Cook Group, BD, Medtronic, Bayer and Opto Circuits, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drug Eluting Balloon for Peripheral Artery Disease manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drug Eluting Balloon for Peripheral Artery Disease Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease Market Segment Percentages, by Type, 2021 (%)
3μg/ mm2
2μg/ mm2
Others
Global Drug Eluting Balloon for Peripheral Artery Disease Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgery Centers
Catheterization Laboratories
Others
Global Drug Eluting Balloon for Peripheral Artery Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Drug Eluting Balloon for Peripheral Artery Disease Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drug Eluting Balloon for Peripheral Artery Disease revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Drug Eluting Balloon for Peripheral Artery Disease revenues share in global market, 2021 (%)
Key companies Drug Eluting Balloon for Peripheral Artery Disease sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Drug Eluting Balloon for Peripheral Artery Disease sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cook Group
BD
Medtronic
Bayer
Opto Circuits